Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Invasive Determination of Fetal Chromosome Abnormalities

NCT00891852 is registered in ClinicalTrials.gov with Lenetix Medical Screening Laboratory as lead sponsor.

NCT NCT00891852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00891852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Invasive Determination of Fetal Chromosome Abnormalities
Lead sponsor
Lenetix Medical Screening Laboratory
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2009
Completion date
December 31, 2009
Enrollment
1,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

abnormalities., and other chromosome, down syndrome (trisomy 21), edward's syndrome (trisomy 18), klinefelter syndrome (47, xxy), patau syndrome (trisomy 13)